A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00122850
Recruitment Status : Completed
First Posted : July 22, 2005
Last Update Posted : November 6, 2007
Boehringer Ingelheim
Information provided by:
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : November 2005
Publications automatically indexed to this study by Identifier (NCT Number):